When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Esophageal cancer - Wikipedia

   en.wikipedia.org/wiki/Esophageal_cancer

   Esophageal cancer; Other names: Oesophageal cancer: Endoscopic image of an esophageal adenocarcinoma: Specialty: Gastroenterology General surgery oncology: Symptoms: Difficulty swallowing, weight loss, hoarse voice, enlarged lymph nodes around the collarbone, vomiting blood, [1] blood in the stool

3. US FDA approves BeiGene's esophageal cancer therapy - AOL

   www.aol.com/news/us-fda-approves-beigenes...

   The therapy, branded as Tevimbra, was approved as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carcinoma. The American Cancer Society estimates there ...

4. Gastrointestinal cancer - Wikipedia

   en.wikipedia.org/wiki/Gastrointestinal_cancer

   Barrett's esophagus is the dominant pre-malignant lesion of esophageal adenocarcinoma, [18] and has prevalent epigenetic alterations. [19] Esophageal squamous-cell carcinomas may occur as second primary tumors associated with head and neck cancer, due to field cancerization (i.e. a regional reaction to long-term carcinogenic exposure).

5. Oesophagogastric junctional adenocarcinoma - Wikipedia

   en.wikipedia.org/wiki/Oesophagogastric_junction...

   Oesophagogastric junctional adenocarcinoma (OGJ adenocarcinoma) is a cancer of the lower part of the oesophagus with a rising incidence in Western countries. [1] This disease is often linked to Barrett's oesophagus. H&E stain of esophageal adenocarcinoma

6. Endoscopic mucosal resection - Wikipedia

   en.wikipedia.org/wiki/Endoscopic_mucosal_resection

   In a preliminary report from Germany, it was performed as primary treatment or adjunctive therapy following photodynamic therapy for early adenocarcinomas in Barrett's esophagus. The "suck and cut" technique (both with and without prior saline injection) was used, as well as the "band and cut" technique.

7. Tislelizumab - Wikipedia

   en.wikipedia.org/wiki/Tislelizumab

   Tislelizumab "demonstrated efficacy and tolerability" in a multicenter phase III trial for advanced hepatocellular carcinoma started in January 2018. [7] [22] In November 2024, the European Medicines Agency expanded the indication of tislelizumab as part of a first-line combination treatment for adults with advanced gastric or esophageal cancer ...